Companies illegally selling unapproved Eli Lily weight loss drug Retatrutide online
Retatrutide, an experimental weight loss drug still undergoing clinical trials at Eli Lily, is being marketed online and illegally sold to U.S. clients, a CBS News investigation found.
CBS News investigative reporter and producer Daniel Gilbert has the story.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.cbsnews.com — the content belongs to CBS News.